A&M and Celltex partner on stem cell Alzheimer’s research – Chron.com
Chron.com |
A&M and Celltex partner on stem cell Alzheimer’s research
Chron.com Texas A&M University Health Science Center is partnering with the Sugar Land company that ran into trouble with federal regulators a year after facilitating the 2011 stem–cell treatment of Gov. Rick Perry’s ailing back. Celltex Therapeutics Corp. and A … Texas A&M, Houston’s Celltex team up to research Alzheimer’s therapiesHouston Business Journal Texas A&M Institute for Regenerative Medicine and Celltex Therapeutics Enter Agreement for Alzheimer’s ResearchDigital Journal |
Chron.com |
A&M and Celltex partner on stem cell Alzheimer’s research
Chron.com Texas A&M University Health Science Center is partnering with the Houston company that ran into trouble with federal regulators a year after facilitating the 2011 stem–cell treatment of Gov. Rick Perry’s ailing back. Celltex Therapeutics Corp. and A&M … Texas A&M, Celltex Therapeutics to research Alzheimer’s therapies …Houston Business Journal |
Rare Disease Report |
CHLA Takes On Trial of Potential Stem Cell Procedure in Treating HLHS
Rare Disease Report CHLA Takes On Trial of Potential Stem Cell Procedure in Treating HLHS. FEBRUARY 06, 2018. Kaitlynn Ely. Children’s Hospital Los Angeles (CHLA) has announced that it will be participating in a new clinical trial with the hopes of improving quality of … |
Science Daily |
New CRISPR method efficiently corrects Duchenne muscular dystrophy defect in heart tissue
Science Daily The work builds upon previous CRISPR research from Dr. Eric Olson, including studies from 2014, 2016 and 2017. The research, the cover story of this month’s Science Advances, builds upon previous studies from Dr. Olson in which CRISPR-Cas9 corrected a … Two Types of CRISPR Gene Editing Could Be Useful in Treating Sickle Cell Anemia, Editas ReportsSickle Cell Anemia News Cut and Paste: How China is Exploring Human Genome Editing …Sputnik International |